Nauka i natura

Creative Biolabs

anti EBNA3A TCR from Creative Biolabs that has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 255-III clinical trials. https://www.creative-biolabs.com/car-t/target-ebna3a-113.htm
Momencik, trwa przetwarzanie danych   loading-animation